Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma.

The article investigates the role of inflammatory cues in the development of asthma in horses, specifically focusing on a molecule named Lipopolysaccharide (LPS). The researchers found that exposure to LPS led to heightened inflammation and increased sensitivity in the bronchi of horses, with IL-6 as the potential trigger. They conclude that neutralizing IL-6 through specific antibodies could potentially treat equine asthma.

Objective of the Study

• The primary goal of the research is to understand the molecular targets that could be used to counteract airway hyperresponsiveness (AHR) in horses suffering from asthma. The researchers aim to draw a relationship between the inflammatory and contractile profiles in bronchi isolated from horses challenged with Lipopolysaccharide (LPS) which has a crucial modulating role in airway inflammation and dysfunction.

Inflammation and Airway Contraction

• Bronchi from horses were exposed to varying concentrations of LPS and then subjected to electrical field stimulation (EFS). They found that LPS at 1 ng/ml significantly increased the bronchi’s contractile response which is indicative of AHR.
• LPS exposure also increased the levels of various inflammation markers like IL-4, IL-5, IL-6, IL-13, IL-1β, IL-33, TGF-β, TNF-α, CXCL-8, EOTAXIN, MCP-1, RANTES, and NKA – all of which can contribute to heightened inflammation and result in asthma-like symptoms.

The Role of IL-6

• Among all the markers studied, only Interleukin-6 (IL-6) demonstrated matching results with AHR across a broad frequency spectrum of EFS.
• Blocking IL-6 with an antibody significantly reduced the AHR response to EFS, indicating that IL-6 could be a potential target in treating asthma. This finding was further confirmed when external IL-6 resulted in a similar AHR level to those induced by LPS.

Additional Factors

• In addition to IL-6, the researchers found a role for capsaicin-sensitive sensory nerves, neurokinin-2 (NK) receptor, and transient receptor potential vanilloid type 1 receptors (TRPV1) in contributing to LPS-induced inflammation.
• Removal of the bronchi’s epithelium also regulated the release of IL-1β, IL-33, and TGF-β, indicating the tissue’s involvement in the inflammatory process.

Conclusions

• The study suggests that IL-6 may be a potential therapeutic target for helping to manage equine asthma, especially in severe cases.
• The researchers indicate that the use of specific antibodies against IL-6 could be a promising strategy for treatment.